Fluorescence polarization method to characterize macrolide-ribosome interactions

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 8, 2005, Pages 3367-3372

  Yan, Kang ^a,c   Hunt, Eric ^b   Berge, John ^b   May, Earl ^a   Copeland, Robert A ^a   Gontarek, Richard R ^a  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CERULENIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; JOSAMYCIN; KETOLIDE; KITASAMYCIN; MACROLIDE; PSEUDOMONIC ACID; RIFAMYCIN; ROKITAMYCIN; TETRACYCLINE; TYLOSIN;

ARTICLE; DISSOCIATION CONSTANT; DRUG BINDING; ESCHERICHIA COLI; FLUORESCENCE POLARIZATION; NONHUMAN; PRIORITY JOURNAL; RIBOSOME; STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; BINDING SITES; ERYTHROMYCIN; ESCHERICHIA COLI; FLUORESCENCE POLARIZATION; MACROLIDES; RIBOSOMES; RNA, RIBOSOMAL;

EID: 23044443510     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.8.3367-3372.2005     Document Type: Article

References (26)

1. Bligh, S. W. A., T. Haley, and P. N. Lowe. 2003. Measurement of dissociation constants of inhibitors binding to Src HS2 domain protein by non-covalent electrospray ionization mass spectrometry. J. Mol. Recognit. 16:139-147.
2. Brain, E. G., A. K. Forrest, E. Hunt, C. Shillingford, and J. M. Wilson. 1989. Erythromycin A oxime 11,12-carbonate and its oxime ethers. J. Antibiot. 42:1817-1822.
3. Brandt-Kauf, P., R. Vince, R. LeMahieu, and S. Pestra. 1978. Fluorescent assay for estimating the binding of erythromycin derivatives to ribosomes. Antimicrob. Agents Chemother. 14:88-94.
4. Copeland, R. A. 2000. Enzymes: a practical introduction to structure, mechanism and data analysis, 2nd ed. Wiley-VCH, New York, N.Y.
5. Costa, A. M., and J. Vilarrasa. 2000. Hybrids of macrolides and nucleobases or nucleosides. Tetrahedron Lett. 41:3371-3375.
6. Dinos, G. P., S. R. Connell, K. H. Nierhaus, and D. L. Kapaxis. 2003. Erythromycin, roxithromycin, and clarithromycin: use of slow-binding kinetics to compare their in vitro interaction with a bacterial ribosomal complex active in peptide bond formation. Mol. Pharmacol. 63:617-623.
7. Garza-Ramos, G., L. Xiong, P. Zhong, and A. Mankin. 2001. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA. J. Bacteriol. 183:6898-6907.
8. Gaynor, M., and S. Mankin. 2003. Macrolide antibiotics: binding site, mechanism of action, resistance. Curr. Top. Med. Chem. 3:949-961.
9. Giambattista, M. D., Y. Engelborghs, E. Nysen, and C. Cocito. 1987. Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes. J. Biol. Chem. 262:8591-8597.
10. Goldman, R. C., S. W. Fesik, and C. C. Doran. 1990. Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria. Antimicrob. Agents Chemother. 34:426-431.
11. Goldman, R. C., D. Zakula, R. Flamm, J. Beyer, and J. Capobianco. 1994. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob. Agents Chemother. 38: 1496-1500.
12. Hansen, J. L., J. A. Ippolito, N. Ban, P. Nissen, P. B. Moore, and T. A. Steitz. 2002. The structures of four macrolide antibiotics bound to the large ribosome subunit. Mol. Cell 10:117-128.
13. Heyduk, T., Y. Ma, H. Tang, and R. H. Ebright. 1996. Fluorescence anisotropy: rapid, quantitative assay for protein-DNA and protein-protein interaction. Methods Enzymol. 274:492-503.
14. Hunt, E., D. J. C. Knowles, C. Shillingford, and I. I. Zomaya. 1988. Erythromycin A 11,12-methylene acetal. J. Antibiot. 41:1644-1648.
15. Hunt, E., D. J. C. Knowles, C. Shillingford, J. M. Wilson, and I. I. Zomaya. 1989. 9,11-Cyclic acetal derivatives of (9S)-9-dihydroerythromycin A. J. Antibiot. 42:293-298.
16. Kurath, P., P. H. Jones, R. S. Egan, and T. J. Perun. 1971. Acid degradation of erythromycin A and erythromycin B. Experientia 27:362.
17. Langlois, R., C. R. Cantor, R. Vince, and S. Pestka. 1977. Interaction between the erythromycin and chloramphenicol binding sites on the Escherichia coli ribosome. Biochemistry 16:2349-2356.
18. Motulsky, H., and A. Christopoulos. 2003. Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting. GraphPad Software Inc., San Diego, Calif.
19. 14C]erythromycin to Escherichia coli ribosomes. Antimicrob. Agents Chemother. 6:474-478.
20. Ryden, R., G. H. Timms, D. M. Prime, and E. Wildsmith. 1973. N-Substituted derivatives of erythromycylamine. J. Med. Chem. 16:1059-1060.
21. Schlünzen, F., R. Zarizach, J. Harms, A. Bashan, A. Tocilj, R. Alrecht, A. Yonath, and F. Franceschi. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413: 814-821.
22. Southwaite, S., and C. Aagaard. 1993. Erythromycin binding is reduced in ribosomes with conformational alterations in the 23S rRNA peptidyl transferase loop. J. Mol. Biol. 232:725-731.
23. Sportsman, J. R., S. K. Lee, H. Dilley, and R. Bukar. 1997. High throughput screening: the discovery of bioactive substances, p. 389-400. Marcel Dekker, New York, N.Y.
24. Staehelin, T., and D. T. Maglott. 1971. The preparation of Escherichia coli ribosomal subunits active in polypeptide synthesis. Methods Enzymol. 20: 449-456.
25. Turconi, S., K. Shea, S. Ashman, K. Fantom, D. L. Earnshaw, R. P. Bingham, U. M. Haupts, M. J. B. Brown, and A. J. Pope. 2001. Real experience of uHTS: a prototypic 1536-well fluorescence anisotropy-based uHTS screen and application of well-level quality control procedures. J. Biomol. Screen. 6:275-290.
26. Wilson, J. M., P. C. T. Hannan, C. Shillingford, and D. J. C. Knowles. 1989. Biological property of ER 42859, a novel erythromycin derivative. J. Antibiot. 42:454-462.